Urolithiasis in HIV-positive patients treated with atazanavir.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 17879904.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Among protease inhibitors, atazanavir has not been associated with urolithiasis in clinical studies. We describe 11 cases of atazanavir-associated urolithiasis in patients with human immunodeficiency virus (HIV) infection. Patients with low water intake, high urinary pH, and a prior history of urinary stones may have a higher risk of atazanavir-associated urine crystallization.
Medical subject headings
- HIV Infections
- HIV Protease Inhibitors
- Oligopeptides
- Pyridines
- Urolithiasis